Biotech | July 31, 2025
Fortis and Agilus expand rapid genomic testing capabilities
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
Subscribe To Our Newsletter & Stay Updated
